Drug Profile
Research programme: CD26 antigen antagonists - Eisai
Alternative Names: Dipeptidyl peptidase IV anatagonists - Eisai; DPP-4 antagonists - EisaiLatest Information Update: 25 Jul 2007
Price :
$50
*
At a glance
- Originator Eisai Co Ltd
- Class Antihyperglycaemics
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 25 Jul 2007 Discontinued - Preclinical for Type-2 diabetes mellitus in Japan (unspecified route)
- 14 Sep 2004 Preclinical trials in Type-2 diabetes mellitus in Japan (unspecified route)